| P2093 | author name string | Thomas Abell | |
| | Nanlong Liu | |
| P2860 | cites work | Twenty-five years of advocacy for patients with gastroparesis: support group therapy and patient reported outcome tool development | Q27313265 |
| | Loss of Interstitial Cells of Cajal and Patterns of Gastric Dysrhythmia in Patients With Chronic Unexplained Nausea and Vomiting | Q27333512 |
| | Extrapyramidal reactions with metoclopramide | Q28362373 |
| | The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. | Q30467463 |
| | Erythromycin: a motilin agonist and gastrointestinal prokinetic agent | Q30467680 |
| | Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis | Q30467734 |
| | Viral gastroparesis: a subgroup of idiopathic gastroparesis--clinical characteristics and long-term outcomes. | Q30471079 |
| | Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease | Q30471423 |
| | Postoperative gastrointestinal complaints after laparoscopic Nissen fundoplication | Q33435276 |
| | Clinical guideline: management of gastroparesis | Q34034345 |
| | Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial | Q34056901 |
| | Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. | Q34111688 |
| | Advantages of Azithromycin Over Erythromycin in Improving the Gastric Emptying Half-Time in Adult Patients With Gastroparesis | Q34298283 |
| | Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride | Q34377869 |
| | Cyclic vomiting syndrome in adults: clinical features and response to tricyclic antidepressants | Q34505349 |
| | Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis | Q34526797 |
| | Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis | Q34558266 |
| | Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study | Q34693031 |
| | Effect of itopride on gastric emptying in longstanding diabetes mellitus | Q34733772 |
| | Motilides: a long and winding road: lessons from mitemcinal (GM-611) on diabetic gastroparesis | Q34974146 |
| | Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying | Q35068824 |
| | A systematic review of surgical therapy for gastroparesis | Q35565623 |
| | Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management | Q35595825 |
| | Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population | Q35758780 |
| | Gastric motility disorders: management that optimizes nutritional status | Q35825549 |
| | American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis | Q35936586 |
| | Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium | Q35962949 |
| | Temporary Endoscopic Stimulation in Gastroparesis-like Syndrome. | Q36211741 |
| | Treatment of gastroparesis: a multidisciplinary clinical review | Q36428532 |
| | Recent advances in the pathophysiology and treatment of gastroparesis | Q36542667 |
| | Immunomodulation for treatment of drug and device refractory gastroparesis | Q36689928 |
| | Tricyclic antidepressants for chronic vomiting in diabetic patients | Q36695351 |
| | Mechanisms of disease: the pathological basis of gastroparesis--a review of experimental and clinical studies | Q36836634 |
| | Interstitial cells of Cajal in health and disease | Q37134544 |
| | The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. | Q37250932 |
| | Autonomic Evaluation of Patients With Gastroparesis and Neurostimulation: Comparisons of Direct/Systemic and Indirect/Cardiac Measures | Q37311664 |
| | Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement | Q37896529 |
| | Azithromycin for the treatment of gastroparesis | Q38085277 |
| | 13C-octanoic acid breath test to study gastric emptying time | Q38180073 |
| | Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial | Q39334423 |
| | Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial | Q39423996 |
| | Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review | Q41150653 |
| | The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders | Q42558135 |
| | Prokinetics in patients with gastroparesis: a systematic analysis | Q42609247 |
| | Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies | Q43226831 |
| | Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis | Q43238929 |
| | A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis | Q44860382 |
| | Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis | Q44974485 |
| | Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility | Q45764127 |
| | The use of tegaserod in critically ill patients with impaired gastric motility. | Q46551922 |
| | Effect of cigarette smoking on gastric emptying of solids in Japanese smokers: a crossover study using the 13C-octanoic acid breath test | Q46592971 |
| | The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus | Q46721518 |
| | Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years | Q46842711 |
| | Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials | Q46927837 |
| | Abdominal pain is a frequent symptom of gastroparesis | Q48358308 |
| | Nausea and vomiting in diabetic and idiopathic gastroparesis | Q48535550 |
| | Blood glucose concentration influences postprandial fullness in IDDM. | Q48745573 |
| | Gastric electrical stimulation modulates neuronal activity in nucleus tractus solitarii in rats | Q48886345 |
| | Direct percutaneous endoscopic jejunostomy: outcomes in 307 consecutive attempts | Q50118998 |
| | Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. | Q51947880 |
| | Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? | Q53311152 |
| | A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. | Q53763499 |
| | Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats | Q57942614 |
| | Effect of ethanol and commonly ingested alcoholic beverages on gastric emptying and gastrointestinal transit | Q67551270 |
| | Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies | Q68741659 |
| | Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting | Q70177918 |
| | Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus | Q70245065 |
| | Inhibition of nitric oxide synthase delays gastric emptying of solid meals | Q71657432 |
| | Combined carbon-13-glycine/carbon-14-octanoic acid breath test to monitor gastric emptying rates of liquids and solids | Q72405165 |
| | Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis | Q72752896 |
| | Appraisal of medium- and long-term treatment of gastroparesis and chronic intestinal dysmotility | Q72760283 |
| | Gastric electrical stimulation in intractable symptomatic gastroparesis | Q73014612 |
| | Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus | Q73475858 |
| | Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats | Q73835495 |
| | Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats | Q73867394 |
| | GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications | Q77844995 |
| | Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine | Q80737881 |
| | Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects | Q81528828 |
| | Motility: Is 'ICC-opathy' present in gastroparesis-like syndrome? | Q85383280 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| | disease management | Q883708 |
| | gastroparesis | Q943897 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 579-589 | |
| P577 | publication date | 2017-05-25 | |
| | 2017-09-15 | |
| P1433 | published in | Gut and liver | Q26841957 |
| P1476 | title | Gastroparesis Updates on Pathogenesis and Management | |
| P478 | volume | 11 | |